6 Citations (Scopus)
57 Downloads (Pure)

Abstract

Electrochemical enzyme-linked immunosorbent assay (ELISA)-based immunoassays for cancer biomarker detection have recently attracted much interest owing to their higher sensitivity, amplification of signal, ease of handling, potential for automation and combination with miniaturized analytical systems, low cost and comparative simplicity for mass production. Their developments have considerably improved the sensitivity required for detection of low concentrations of cancer biomarkers present in bodily fluids in the early stages of the disease. Recently, various attempts have been made in their development and several methods and processes have been described for their development, amplification strategies and testing. The present review mainly focuses on the development of ELISA-based electrochemical immunosensors that may be utilized for cancer diagnosis, prognosis and therapy monitoring. Various fabrication methods and signal enhancement strategies utilized during the last few years for the development of ELISA-based electrochemical immunosensors are described.
Original languageEnglish
Article number2010
Pages (from-to)1-45
Number of pages45
JournalSensors
Volume18
Issue number7
DOIs
Publication statusPublished - 22 Jun 2018

Fingerprint

Immunosorbents
immunoassay
biomarkers
Tumor Biomarkers
Immunoassay
enzymes
Immunosensors
Assays
Enzymes
cancer
Enzyme-Linked Immunosorbent Assay
Amplification
augmentation
Automation
prognosis
sensitivity
Costs and Cost Analysis
Fabrication
automation
Fluids

Keywords

  • Electrochemical ELISA
  • serum
  • Immunoassay
  • Antibodies
  • cancer
  • Biosensors
  • Cancer detection
  • Serum

ASJC Scopus subject areas

  • Analytical Chemistry
  • Instrumentation
  • Atomic and Molecular Physics, and Optics
  • Electrical and Electronic Engineering
  • Biochemistry

Cite this

Recent Advances in Enhancement Strategies for Electrochemical ELISA-Based Immunoassays for Cancer Biomarker Detection. / Arya, Sunil; Estrela, Pedro.

In: Sensors, Vol. 18, No. 7, 2010, 22.06.2018, p. 1-45.

Research output: Contribution to journalReview article

@article{d28b3790d2854d37aa1742f76e6719ca,
title = "Recent Advances in Enhancement Strategies for Electrochemical ELISA-Based Immunoassays for Cancer Biomarker Detection",
abstract = "Electrochemical enzyme-linked immunosorbent assay (ELISA)-based immunoassays for cancer biomarker detection have recently attracted much interest owing to their higher sensitivity, amplification of signal, ease of handling, potential for automation and combination with miniaturized analytical systems, low cost and comparative simplicity for mass production. Their developments have considerably improved the sensitivity required for detection of low concentrations of cancer biomarkers present in bodily fluids in the early stages of the disease. Recently, various attempts have been made in their development and several methods and processes have been described for their development, amplification strategies and testing. The present review mainly focuses on the development of ELISA-based electrochemical immunosensors that may be utilized for cancer diagnosis, prognosis and therapy monitoring. Various fabrication methods and signal enhancement strategies utilized during the last few years for the development of ELISA-based electrochemical immunosensors are described.",
keywords = "Electrochemical ELISA, serum, Immunoassay, Antibodies, cancer, Biosensors, Cancer detection, Serum",
author = "Sunil Arya and Pedro Estrela",
year = "2018",
month = "6",
day = "22",
doi = "10.3390/s18072010",
language = "English",
volume = "18",
pages = "1--45",
journal = "Sensors",
issn = "1424-8220",
publisher = "MDPI",
number = "7",

}

TY - JOUR

T1 - Recent Advances in Enhancement Strategies for Electrochemical ELISA-Based Immunoassays for Cancer Biomarker Detection

AU - Arya, Sunil

AU - Estrela, Pedro

PY - 2018/6/22

Y1 - 2018/6/22

N2 - Electrochemical enzyme-linked immunosorbent assay (ELISA)-based immunoassays for cancer biomarker detection have recently attracted much interest owing to their higher sensitivity, amplification of signal, ease of handling, potential for automation and combination with miniaturized analytical systems, low cost and comparative simplicity for mass production. Their developments have considerably improved the sensitivity required for detection of low concentrations of cancer biomarkers present in bodily fluids in the early stages of the disease. Recently, various attempts have been made in their development and several methods and processes have been described for their development, amplification strategies and testing. The present review mainly focuses on the development of ELISA-based electrochemical immunosensors that may be utilized for cancer diagnosis, prognosis and therapy monitoring. Various fabrication methods and signal enhancement strategies utilized during the last few years for the development of ELISA-based electrochemical immunosensors are described.

AB - Electrochemical enzyme-linked immunosorbent assay (ELISA)-based immunoassays for cancer biomarker detection have recently attracted much interest owing to their higher sensitivity, amplification of signal, ease of handling, potential for automation and combination with miniaturized analytical systems, low cost and comparative simplicity for mass production. Their developments have considerably improved the sensitivity required for detection of low concentrations of cancer biomarkers present in bodily fluids in the early stages of the disease. Recently, various attempts have been made in their development and several methods and processes have been described for their development, amplification strategies and testing. The present review mainly focuses on the development of ELISA-based electrochemical immunosensors that may be utilized for cancer diagnosis, prognosis and therapy monitoring. Various fabrication methods and signal enhancement strategies utilized during the last few years for the development of ELISA-based electrochemical immunosensors are described.

KW - Electrochemical ELISA

KW - serum

KW - Immunoassay

KW - Antibodies

KW - cancer

KW - Biosensors

KW - Cancer detection

KW - Serum

UR - http://www.scopus.com/inward/record.url?scp=85049014105&partnerID=8YFLogxK

U2 - 10.3390/s18072010

DO - 10.3390/s18072010

M3 - Review article

VL - 18

SP - 1

EP - 45

JO - Sensors

JF - Sensors

SN - 1424-8220

IS - 7

M1 - 2010

ER -